Mizuho Analyst On The Fence At Medicines Co. Pending Patent Appeal By: Benzinga via Benzinga April 11, 2015 at 12:49 PM EDT Uncertainty over patents on The Medicines Company (NASDAQ: MDCO)'s lead blood-clot drug Angiomax will hurt results going forward, ... Read More >> Related Stocks: Hospira Medicines Company